KNRS Share Price Performance
CHF 0
0.00 (0.00%)
Sorry, there is currently no price data for this company.
Kinarus Therapeutics Holding AG Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
KNRS Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
Kinarus Therapeutics Holding AG Key Details
About KNRS
- Founded
- 2017
- Employees
- n/a
- CEO
- WebsiteView website
Kinarus Therapeutics Holding AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapeutics for the treatment of viral, respiratory, and ophthalmic diseases. Its therapeutic drug candidate is KIN001, an advanced clinical stage p38 mitogen-activated protein kinase inhibitor combined with a marketed drug together enabling an oral long-term treatment for patients suffering from diseases. The company was founded in 2017 and is based in Basel, Switzerland.